Disease-associated HCN4 V759I variant is not sufficient to impair cardiac pacemaking

Nadine Erlenhardt1, Olaf Kletke1, Franziska Wohlfarth1

  • 1Institute of Neurophysiology, Medical Faculty, University of Düsseldorf, Universitätsstr 1, 40225, Düsseldorf, Germany.

Insights

The HCN4 V759I genetic variant, previously suspected of causing heart rhythm disorders, does not appear to affect cardiac pacemaker function. Functional studies found no abnormalities, suggesting it is not pathogenic for sick sinus syndrome.

Area of Science:

  • Cardiology
  • Genetics
  • Molecular Biology

Background:

  • The hyperpolarization-activated cation current (If) governs cardiac pacemaker activity, primarily through HCN4 channel subunits.
  • HCN4 gene mutations are linked to sinus node dysfunction, but their precise functional impact remains unclear.
  • A specific HCN4 V759I variant was identified in a patient with a family history of sick sinus syndrome.

Observation:

  • Genomic analysis revealed a mono-allelic HCN4 V759I variant in a patient with familial sick sinus syndrome.
  • This variant was previously considered potentially pathogenic due to associations with sudden infant death syndrome and epilepsy.
  • Electrophysiological and cell biological studies were performed using Xenopus laevis oocytes and embryonic rat cardiomyocytes.

Findings:

  • Functional characterization of the HCN4 V759I variant showed no significant abnormalities in channel activation, cAMP-gating, or cell surface expression compared to wild-type.
  • The patient's mother, also affected by sick sinus syndrome, did not carry the HCN4 V759I variant.
  • The HCN4 V759I variant did not demonstrate any functional disturbance in cardiac pacemaking.

Implications:

  • The HCN4 V759I variant appears to be an innocuous genetic finding, insufficient to cause cardiac pacemaking disturbances.
  • This study underscores the critical need for rigorous functional validation of genetic variants associated with hereditary cardiac arrhythmias.
  • Accurate interpretation of genetic findings is essential to avoid misattributing pathogenicity to benign variants.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
227
Mechanism of Cardiac Arrhythmias01:28

Mechanism of Cardiac Arrhythmias

Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
1.5K
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
288
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
257
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
172
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
341